1206968-55-9

Upstream product

• 88139-91-7 (5-bromopyridin-2-yl)methanol 
• 286961-15-7 benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1 (2H)-pyridinecarboxylate 

Downstream Products

• 1206967-84-1 tert-Butyl 4-[2-[3-fluoro-4-((R)-2-hydroxy-1-methylethylcarbamoyl)phenoxymethyl]pyridin-5-yl]piperidine-1-carboxylate 
• 1206967-90-9 tert-Butyl 4-[2-(4-sulfamoylphenoxymethyl)pyridin-5-yl]piperidine-1-carboxylate 
• 1206968-10-6 1,1-Dimethylpropyl 4-[2-(4-methanesulfonylphenoxymethyl)-pyridin-5-yl]piperidine-1-carboxylate 
• 1206968-17-3 5-Ethyl-2-[4-[2-(4-methanesulfonylphenoxymethyl)pyridin-5-yl]piperidin-1-yl]pyrimidine 
• 1206968-46-8 tert-butyl 4-[2-[(4-methanesulfonylphenylamino)-methyl]pyridin-5-yl]piperidine-1-carboxylate 
• 1206968-47-9 tert-butyl (E)-4-[2-[2-(4-methanesulfonylphenyl)vinyl]pyridin-5-yl]piperidine-1-carboxylate 
• 1206968-53-7 tert-Butyl 4-[2-(4-methanesulfonylphenylthiomethyl)-pyridin-5-yl]piperidine-1-carboxylate 
• 1206968-66-2 4-[2-(4-methanesulfonylphenoxymethyl)pyridin-5-yl]piperidine 
• 1206967-70-5 tert-butyl 4-[2-(4-methanesulfonylphenoxymethyl)-pyridin-5-yl]piperidine-1-carboxylate 
• 1206968-67-3 4-[2-(4-methanesulfonylphenoxymethyl)pyridin-5-yl]piperidin-1-carbonitrile 
• 1206968-68-4 N-Hydroxy-4-[2-(4-methanesulfonylphenoxymethyl)-pyridin-5-yl]piperidin-1-carboxamidine 
• 1206967-77-2 5-[1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)piperidin-4-yl]-2-(4-methanesulfonylphenoxymethyl)pyridine 
• 1206967-78-3 tert-butyl 4-[2-(4-ethoxycarbonyl-3-fluorophenoxymethyl)pyridin-5-yl]piperidine-1-carboxylate 
• 1206967-79-4 tert-butyl 4-[2-(4-carboxy-3-fluorophenoxymethyl)pyridin-5-yl]piperidine-1-carboxylate 

Relevant academic research and scientific papers

GPR119 AGONIST

A compound represented by the formula (II) is a GPR119 agonist, and is used as an agent for treating diabetes: wherein each of R23, R24, and R25 is hydrogen, halogen, C1-8 alkyl, C1-8 alkoxy, C1-

GPR119 AGONIST

A cyclic amine derivative represented by the formula (II) is a GPR119 agonist, and is used as an agent for treating diabetes. wherein Ar0 is phenyl or phenyl having a substituent such as C1-8 alkylsulfonyl or the like, pyridyl, or pyridyl having a substituent such as C1-8 alkylsulfonyl; A0 is (CH2)p, O, or the like; B0 is (CH2)q, or the like, provided that B0 is neither O nor NR25 when A0 is O or NR24; one of U0 and V0 is N, and the other is N or CR26; each of X0\ and Y0 is C1-3 alkylene or C1-3 alkylene having a substituent; R23 is a C1-8 alkyl group or the like; each of R21 and R22 is hydrogen, a halogen atom, or the like.